tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

GEHCGE HealthCare

Health care · Medical Imaging · Nasdaq
Employees
54,000
Headquarters
Chicago, IL
CEO
Peter J. Arduini
Next results
around Feb 3, 2027
Compare with peers → Embed

The biggest changes in the 10-K filed 2026-02-04, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Gross margin

41.7% → 40.0% (-1.7 pts) Big change FY to 2025-12-31 vs 2024-12-31

“Gross profit increased $43 million, but decreased 170 basis points as a percent of Total revenues primarily due to an increase in both Cost of products and Cost of services as a percent of Total revenues.”

Read it in the 10-K ↗

Revenue

+4.8% FY to 2025-12-31 vs 2024-12-31

“Sales of products increased 4.5% or $586 million primarily driven by strong growth in PDx, Imaging, and AVS revenues.”

Read it in the 10-K ↗

“Sales of services increased 5.6% or $368 million primarily driven by growth in new and existing customer contractual agreements.”

Read it in the 10-K ↗

Net income

+4.6% FY to 2025-12-31 vs 2024-12-31

“Net income attributable to GE HealthCare and Net income margin were $2,084 million and 10.1%, an increase of $91 million and flat to the prior year, respectively, primarily due to the following factors:”

Read it in the 10-K ↗

“Other income – net increased $103 million primarily driven by the remeasurement of the Company’s 50% interest in NMP based on the cash consideration exchanged for acquiring the remaining 50% equity interest.”

Read it in the 10-K ↗

Cash from operations

+1.6% FY to 2025-12-31 vs 2024-12-31

The MD&A has no sentence that names a cause for this change. That can be worth a question: ask about the filing.

Operating margin

13.3% → 13.4% (+0.1 pts) FY to 2025-12-31 vs 2024-12-31

“Total operating expenses decreased $95 million, with a decrease in research and development (“R&D”) investments of $51 million, driven by certain programs achieving development milestones resulting in costs to be reported under cost of revenues, and a decrease in Selling, general, and administrative (“SG&A”) expense of $44 million primarily driven by a decrease in Spin-Off and separation costs, partially offset by increased investment in our commercial teams and the acquisition of NMP.”

Read it in the 10-K ↗

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Work on GEHC in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GEHC/export.csv") into a cell.